In part II of this BioPharm International interview, Tarja Mottram, CEO of 

, focuses on “design for value”—a paradigm shift in how the industry measures and provides evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012

BioPharm International interviews Tarja Mottram, CEO of Action for Results, about a paradigm shift in how we measure and provide evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012.